Targeting PDZ to unravel early anesthetic exposure-produced cognitive dysfunction

靶向 PDZ 来解决早期麻醉暴露引起的认知功能障碍

基本信息

  • 批准号:
    8673354
  • 负责人:
  • 金额:
    $ 38.21万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2014
  • 资助国家:
    美国
  • 起止时间:
    2014-05-01 至 2018-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Previous clinical cohort studies and animal studies have shown that early exposure to anesthetics is a significant risk factor for later development of learning disabilities. However, the underlying molecular mechanism is unclear. Several lines of evidence have indicated that impaired hippocampal neurogenesis and synaptogenesis may be involved in the mechanisms by which early anesthetic exposure produces long-term cognitive impairment, and that synaptic scaffolding protein PSD-95 PDZ domain-mediated protein-protein interactions and synaptic activities are involved in the regulation of neurogenesis and synaptogenesis in the hippocampus. Our previous studies have demonstrated that PDZ domain-mediated protein interactions are disrupted by clinically relevant concentrations of inhaled anesthetics. Recently, we showed that exposing postnatal day (PND) 7 rats to isoflurane diminishes hippocampal neurogenesis, inhibits dendritic spine development and synaptic plasticity, and impairs learning and memory function. These results suggest that the disruption of PDZ interactions and PDZ domain-mediated synaptic function may play important roles in the pathogenesis of early anesthetic exposure-produced long-term cognitive impairment. We hypothesize that early exposure of neonatal rats to inhaled anesthetics inhibits neurogenesis and interferes with synaptogenesis by disrupting synaptic PDZ interactions and PDZ domain-mediated synaptic function in the developing hippocampus, thereby producing long-term neurocognitive dysfunction. To address this hypothesis, we will determine whether synaptic PDZ interactions and PDZ domain-mediated synaptic function contribute to the mechanism underlying isoflurane suppression of neurogenesis and inhibition of synaptogenesis (Aim 1); we will determine the cell biological effects of inhaled anesthetic isoflurane-mediated PDZ domain disruption in developing hippocampal neurons in vitro (Am 2); we will further determine whether the disruption of synaptic PDZ interactions and the impairment of PDZ domain-mediated synaptic function contributes to long-term cognitive impairment after early anesthetic exposure (Aim 3). The proposed studies will provide critical evidence to clarify whether early anesthetic exposure produces long-term cognitive impairment by inhibiting PDZ interaction-regulated hippocampal neurogenesis and synaptogenesis. The data will shed new light on the pathogenesis of neonatal anesthetic neurotoxicity. The overall goal of this proposal is to demonstrate the roles of synaptic PDZ interactions and PDZ domain-mediated synaptic function in early anesthetic exposure- produced long-term cognitive impairment.
描述(由申请人提供):先前的临床队列研究和动物研究表明,早期暴露于麻醉剂是日后发生 学习障碍。然而,潜在的分子机制尚不清楚。一些证据表明,受损的海马神经发生和突触发生可能参与早期麻醉暴露产生长期认知障碍的机制,并且突触支架蛋白PSD-95 PDZ结构域介导的蛋白质-蛋白质相互作用和突触活动参与海马神经发生和突触发生的调节。我们之前的研究表明,PDZ结构域介导的蛋白质相互作用会被临床相关浓度的吸入麻醉剂破坏。最近,我们发现,暴露出生后第7天(PND)大鼠异氟烷减少海马神经发生,抑制树突棘发育和突触可塑性,并损害学习和记忆功能。这些结果表明,PDZ相互作用和PDZ结构域介导的突触功能的破坏可能在早期麻醉麻醉药引起的长期认知障碍的发病机制中起重要作用。我们推测,早期暴露的新生大鼠吸入麻醉剂抑制神经发生和干扰突触发育中的海马突触PDZ的相互作用和PDZ域介导的突触功能,从而产生长期的神经认知功能障碍。为了解决这一假设,我们将确定突触PDZ相互作用和PDZ结构域介导的突触功能是否有助于异氟醚抑制神经发生和抑制突触发生的潜在机制(Aim 1);我们将确定吸入麻醉剂异氟醚介导的PDZ结构域破坏在体外发育的海马神经元中的细胞生物学效应(Am 2);我们将进一步确定突触PDZ相互作用的破坏和PDZ结构域介导的突触功能的损害是否有助于早期麻醉剂暴露后的长期认知损害(目的3)。拟议的研究将提供关键证据,以澄清早期麻醉剂暴露是否通过抑制PDZ相互作用调节的海马神经发生和突触发生而产生长期认知障碍。这些数据将为新生儿麻醉神经毒性的发病机制提供新的线索。该提案的总体目标是证明突触PDZ相互作用和PDZ结构域介导的突触功能在早期麻醉剂暴露产生的长期认知障碍中的作用。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Roger A Johns其他文献

Increased Pulmonary Blood Flow as a Regulator of Pulmonary Vascular Remodeling: Role of eNOS ♦ 105
  • DOI:
    10.1203/00006450-199704001-00126
  • 发表时间:
    1997-04-01
  • 期刊:
  • 影响因子:
    3.100
  • 作者:
    Allen D Everett;Timothy D Le Cras;Chun Xue;Roger A Johns
  • 通讯作者:
    Roger A Johns

Roger A Johns的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Roger A Johns', 18)}}的其他基金

Resistin regulates NLRP3 inflammasome in pulmonary hypertension
抵抗素调节肺动脉高压中的 NLRP3 炎性体
  • 批准号:
    10567914
  • 财政年份:
    2023
  • 资助金额:
    $ 38.21万
  • 项目类别:
DAMP Signaling Mediates HIMF-induced Pulmonary Hypertension
DAMP 信号介导 HIMF 诱导的肺动脉高压
  • 批准号:
    9976575
  • 财政年份:
    2018
  • 资助金额:
    $ 38.21万
  • 项目类别:
DAMP Signaling Mediates HIMF-induced Pulmonary Hypertension
DAMP 信号介导 HIMF 诱导的肺动脉高压
  • 批准号:
    10206240
  • 财政年份:
    2018
  • 资助金额:
    $ 38.21万
  • 项目类别:
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity
PDZ 结构域介导的蛋白质相互作用对神经发育和麻醉介导的神经毒性的机制作用
  • 批准号:
    10390873
  • 财政年份:
    2014
  • 资助金额:
    $ 38.21万
  • 项目类别:
Targeting resitin and RELM-beta to treat pulmonary hypertension
靶向抵抗素和 RELM-β 治疗肺动脉高压
  • 批准号:
    8757198
  • 财政年份:
    2014
  • 资助金额:
    $ 38.21万
  • 项目类别:
Targeting PDZ to unravel early anesthetic exposure-produced cognitive dysfunction
靶向 PDZ 来解决早期麻醉暴露引起的认知功能障碍
  • 批准号:
    9016565
  • 财政年份:
    2014
  • 资助金额:
    $ 38.21万
  • 项目类别:
Targeting resitin and RELM-beta to treat pulmonary hypertension
靶向抵抗素和 RELM-β 治疗肺动脉高压
  • 批准号:
    9335421
  • 财政年份:
    2014
  • 资助金额:
    $ 38.21万
  • 项目类别:
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity
PDZ 结构域介导的蛋白质相互作用对神经发育和麻醉介导的神经毒性的机制作用
  • 批准号:
    10649603
  • 财政年份:
    2014
  • 资助金额:
    $ 38.21万
  • 项目类别:
Mechanistic Actions of PDZ Domain Mediated Protein Interactions on Neural Development and Anesthetic-Mediated Neurotoxicity
PDZ 结构域介导的蛋白质相互作用对神经发育和麻醉介导的神经毒性的机制作用
  • 批准号:
    10212402
  • 财政年份:
    2014
  • 资助金额:
    $ 38.21万
  • 项目类别:
Targeting resitin and RELM-beta to treat pulmonary hypertension
靶向抵抗素和 RELM-β 治疗肺动脉高压
  • 批准号:
    8931049
  • 财政年份:
    2014
  • 资助金额:
    $ 38.21万
  • 项目类别:

相似海外基金

Investigation of the mechanism of recovery effect of anesthetics on endothelial glycocalyx damage
麻醉药对内皮糖萼损伤恢复作用的机制探讨
  • 批准号:
    23K08341
  • 财政年份:
    2023
  • 资助金额:
    $ 38.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of a Novel Functional Mechanism of Intravenous Anesthetics Based on the Membrane Lipid Theory and Its Application to Clinical Practice
基于膜脂理论的静脉麻醉药新作用机制的阐明及其在临床实践中的应用
  • 批准号:
    23K06361
  • 财政年份:
    2023
  • 资助金额:
    $ 38.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Disruptions in the brain reward system through postnatal exposure to GABA agonists and anesthetics
产后接触 GABA 激动剂和麻醉剂会扰乱大脑奖励系统
  • 批准号:
    10657509
  • 财政年份:
    2022
  • 资助金额:
    $ 38.21万
  • 项目类别:
Electrophysiological analysis of proarrhythmic properties of volatile anesthetics using an originally developed arrhythmogenic model
使用最初开发的致心律失常模型对挥发性麻醉药的致心律失常特性进行电生理分析
  • 批准号:
    22K09032
  • 财政年份:
    2022
  • 资助金额:
    $ 38.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Modification of the intercellular network of immune cells in tumor microenvironment by sedatives and anesthetics.
通过镇静剂和麻醉剂改变肿瘤微环境中免疫细胞的细胞间网络。
  • 批准号:
    22K09083
  • 财政年份:
    2022
  • 资助金额:
    $ 38.21万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of astrocytes in emergence from volatile anesthetics
星形胶质细胞在挥发性麻醉剂苏醒中的作用
  • 批准号:
    10340339
  • 财政年份:
    2022
  • 资助金额:
    $ 38.21万
  • 项目类别:
Mechanisms and blood-based biomarkers of intergenerational neurobehavioral effects of general anesthetics
全身麻醉药代际神经行为效应的机制和血液生物标志物
  • 批准号:
    10538703
  • 财政年份:
    2022
  • 资助金额:
    $ 38.21万
  • 项目类别:
Disruptions in the brain reward system through postnatal exposure to GABA agonists and anesthetics
产后接触 GABA 激动剂和麻醉剂会扰乱大脑奖励系统
  • 批准号:
    10440005
  • 财政年份:
    2022
  • 资助金额:
    $ 38.21万
  • 项目类别:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
  • 批准号:
    10870632
  • 财政年份:
    2022
  • 资助金额:
    $ 38.21万
  • 项目类别:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
  • 批准号:
    10671023
  • 财政年份:
    2022
  • 资助金额:
    $ 38.21万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了